Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
-3.33%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$23.5B
AUM Growth
-$4.8B
(-17%)
Cap. Flow
-$3.24B
Cap. Flow
% of AUM
-13.8%
Top 10 Holdings %
Top 10 Hldgs %
43.16%
Holding
1,163
New
23
Increased
156
Reduced
878
Closed
105
Top Buys
| 1 |
Tesla
TSLA
|
+$88.8M |
| 2 |
Texas Instruments
TXN
|
+$28.7M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$15.3M |
| 4 |
Palantir
PLTR
|
+$8.77M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$6.82M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$365M |
| 2 |
Broadcom
AVGO
|
+$225M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$197M |
| 4 |
NVIDIA
NVDA
|
+$153M |
| 5 |
Apple
AAPL
|
+$132M |
Sector Composition
| 1 | Technology | 37.65% |
| 2 | Financials | 11.39% |
| 3 | Consumer Discretionary | 6.47% |
| 4 | Healthcare | 4.47% |
| 5 | Industrials | 2.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Paylocity
PCTY
$9.35B
| $205K | ﹤0.01% |
1,096
-357
| -25% | -$66.9K |
|
1027
RenaissanceRe
RNR
$11.6B
| $203K | ﹤0.01% |
844
-342
| -29% | -$82.1K |
|
1028
Duolingo
DUOL
$14.1B
| $202K | ﹤0.01% |
650
-216
| -25% | -$67.1K |
|
1029
Jones Lang LaSalle
JLL
$14.8B
| $202K | ﹤0.01% |
814
-269
| -25% | -$66.7K |
|
1030
Annaly Capital Management
NLY
$14.1B
| $201K | ﹤0.01% |
9,915
-2,887
| -23% | -$58.6K |
|
1031
Stitch Fix
SFIX
$712M
| $200K | ﹤0.01% |
61,558
+23,983
| +64% | +$77.9K |
|
1032
NIO
NIO
$14B
| $191K | ﹤0.01% |
50,109
+14,028
| +39% | +$53.4K |
|
1033
Avantor
AVTR
$8.39B
| $189K | ﹤0.01% |
11,673
-3,873
| -25% | -$62.8K |
|
1034
Lucid Motors
LCID
$5.92B
| $186K | ﹤0.01% |
7,705
+3,662
| +91% | +$88.6K |
|
|
CNH
1035
CNH Industrial
CNH
$13.7B
| $184K | ﹤0.01% |
14,988
-4,981
| -25% | -$61.2K |
|
1036
Arvinas
ARVN
$568M
| $176K | ﹤0.01% |
+25,110
| New | +$176K |
|
|
GTM
1037
ZoomInfo Technologies
GTM
$3.72B
| $156K | ﹤0.01% |
15,592
-5,683
| -27% | -$56.8K |
|
1038
Scilex Holding
SCLX
$183M
| $154K | ﹤0.01% |
17,718
| – | – |
|
1039
JELD-WEN Holding
JELD
$537M
| $147K | ﹤0.01% |
24,663
+89
| +0.4% | +$531 |
|
1040
Organogenesis Holdings
ORGO
$624M
| $138K | ﹤0.01% |
+31,997
| New | +$138K |
|
1041
Arhaus
ARHS
$1.52B
| $135K | ﹤0.01% |
15,568
+55
| +0.4% | +$479 |
|
1042
Nu Holdings
NU
$75.8B
| $120K | ﹤0.01% |
11,743
-4,946
| -30% | -$50.6K |
|
1043
Amneal Pharmaceuticals
AMRX
$3.14B
| $117K | ﹤0.01% |
13,918
-1,745
| -11% | -$14.6K |
|
1044
Wave Life Sciences
WVE
$1.11B
| $106K | ﹤0.01% |
13,171
+705
| +6% | +$5.7K |
|
1045
Luminar Technologies
LAZR
$129M
| $102K | ﹤0.01% |
+18,835
| New | +$102K |
|
1046
QuantumScape
QS
$5.64B
| $97.5K | ﹤0.01% |
23,434
+7,885
| +51% | +$32.8K |
|
1047
Smith & Wesson
SWBI
$415M
| $94.7K | ﹤0.01% |
10,166
-1,316
| -11% | -$12.3K |
|
1048
EVgo
EVGO
$554M
| $93.5K | ﹤0.01% |
35,151
-40,303
| -53% | -$107K |
|
1049
Xeris Biopharma Holdings
XERS
$1.21B
| $82.4K | ﹤0.01% |
15,003
-2,717
| -15% | -$14.9K |
|
1050
Ocular Therapeutix
OCUL
$2.23B
| $81.1K | ﹤0.01% |
11,070
-4,152
| -27% | -$30.4K |
|